Table 2

Change in clinical and echocardiographic parameters from admission to discharge in patients admitted to the hospital for AHF according to LVEF at discharge

AdmissionChange from admission to discharge, Δ [95% CI]
HFrEF
n = 52
HFmrEF
n = 16
HFpEF
n = 66
P-valueHFrEF
n = 52
HFmrEF
n = 16
HFpEF
n = 66
P-value
Body weight (kg)87 (20)90 (21)84 (22)0.363−4.4 (−5.7, −2.8)−3.7 (−6.2, −0.9)−2.6 (−3.8, −1.9)0.032b
NT-proBNP (pg/mL)6152 (4124, 10428)3982 (2457, 5808)2968 (1249, 6397)0.001b−3942 (−5737, −1922)−2008 (−3800, 423)−2392 (−3490, −1063)0.061b
HR (min−1)84 (19)75 (24)74 (17)0.016b−12 (−17, −7)−2 (−11, 8)−7 (−11, −3)0.059
SET (ms)244 (39)279 (36)300 (46)<0.001ab20 (11, 30)−5 (−21, 10)10 (−0, 19)0.025a
SETc (ms)269 (35)294 (27)317 (35)<0.001abc9 (1, 17)−5 (−21, 10)1 (−7, 9)0.110
LVEF (%)25 (8)46 (6)60 (11)<0.001abc11 (7, 15)3 (−1, 8)1 (−2, 3)0.004b
LVEDV (mL)161 (120, 208)100 (64, 134)79 (67, 114)<0.001 ab−9 (−20, 3)−27 (−55, 1)−5 (−12, 4)0.409
SV (mL)39 (27, 48)46 (30, 69)50 (38, 72)0.002b4 (+0, 8)−14 (−27, −1)−1 (−6, 3)0.065a
Cardiac output (L/min)3.2 (2.2, 4.2)3.7 (2.2, 4.5)3.6 (2.8, 4.8)0.222−0.2 (−0.6, 0.2)−1.1 (−2.0, −0.3)−0.5 (−0.9, −0.1)0.334
E/e´19 (13, 25)20 (16, 20)17 (12, 22)0.5904 (−7,12)13 (+0, 25)2 (−1, 5)0.577
TRmaxPG (mmHg)41 (11)41 (15)44 (14)0.502−3 (−6, + 0)−4 (−10, 2)−6 (−9, −3)0.539
Ea (mmHg/mL)2.85 (2.20, 3.76)1.94 (1.72, 3.50)2.43 (1.67, 3.07)0.038b−0.46 (−0.82, −0.05)0.63 (−0.46, 1.64)0.06 (−0.36, 0.43)0.114
Ees (mmHg/mL)0.93 (0.65, 1.20)2.28 (1.43, 2.95)3.87 (2.76, 5.22)<0.001abc0.07 (−0.06, 0.18)0.45 (−0.75, 1.60)0.18 (−0.40, 0.71)0.706
AdmissionChange from admission to discharge, Δ [95% CI]
HFrEF
n = 52
HFmrEF
n = 16
HFpEF
n = 66
P-valueHFrEF
n = 52
HFmrEF
n = 16
HFpEF
n = 66
P-value
Body weight (kg)87 (20)90 (21)84 (22)0.363−4.4 (−5.7, −2.8)−3.7 (−6.2, −0.9)−2.6 (−3.8, −1.9)0.032b
NT-proBNP (pg/mL)6152 (4124, 10428)3982 (2457, 5808)2968 (1249, 6397)0.001b−3942 (−5737, −1922)−2008 (−3800, 423)−2392 (−3490, −1063)0.061b
HR (min−1)84 (19)75 (24)74 (17)0.016b−12 (−17, −7)−2 (−11, 8)−7 (−11, −3)0.059
SET (ms)244 (39)279 (36)300 (46)<0.001ab20 (11, 30)−5 (−21, 10)10 (−0, 19)0.025a
SETc (ms)269 (35)294 (27)317 (35)<0.001abc9 (1, 17)−5 (−21, 10)1 (−7, 9)0.110
LVEF (%)25 (8)46 (6)60 (11)<0.001abc11 (7, 15)3 (−1, 8)1 (−2, 3)0.004b
LVEDV (mL)161 (120, 208)100 (64, 134)79 (67, 114)<0.001 ab−9 (−20, 3)−27 (−55, 1)−5 (−12, 4)0.409
SV (mL)39 (27, 48)46 (30, 69)50 (38, 72)0.002b4 (+0, 8)−14 (−27, −1)−1 (−6, 3)0.065a
Cardiac output (L/min)3.2 (2.2, 4.2)3.7 (2.2, 4.5)3.6 (2.8, 4.8)0.222−0.2 (−0.6, 0.2)−1.1 (−2.0, −0.3)−0.5 (−0.9, −0.1)0.334
E/e´19 (13, 25)20 (16, 20)17 (12, 22)0.5904 (−7,12)13 (+0, 25)2 (−1, 5)0.577
TRmaxPG (mmHg)41 (11)41 (15)44 (14)0.502−3 (−6, + 0)−4 (−10, 2)−6 (−9, −3)0.539
Ea (mmHg/mL)2.85 (2.20, 3.76)1.94 (1.72, 3.50)2.43 (1.67, 3.07)0.038b−0.46 (−0.82, −0.05)0.63 (−0.46, 1.64)0.06 (−0.36, 0.43)0.114
Ees (mmHg/mL)0.93 (0.65, 1.20)2.28 (1.43, 2.95)3.87 (2.76, 5.22)<0.001abc0.07 (−0.06, 0.18)0.45 (−0.75, 1.60)0.18 (−0.40, 0.71)0.706

Value are given as mean (SD) or median (Q1, Q3), as appropriate. The difference (Δ) admission to discharge was calculated subtracting the admission value from the discharge value; hence, a difference >0 indicates a prolongation of SET or SETc from admission to discharge, respectively. The respective information was available in ≥80% of participants, except for: ΔEa (n = 94), ΔLVEDV (n = 96), and E/e´ (n = 66). Pairwise comparisons, P < 0.05: a = HFrEF vs. HFmrEF, b = HFrEF vs. HFpEF, c = HFmrEF vs. HFpEF.

HFrEF, HF with reduced EF (LVEF ≤ 40%); HFmrEF, HF with mildly reduced EF (LVEF41–49%); HFpEF, HF with preserved EF (LVEF ≥ 50%); HR, heart rate; NT-proBNP, N-terminal pro B-type natriuretic peptide; SET, systolic ejection time; SETc, HR-corrected SET; LVEF, left ventricular ejection fraction; LVEDV, left ventricular end-diastolic volume; SV, stroke volume; E, early mitral inflow velocity; e´, early diastolic velocity of the mitral annulus; TRmaxPG, maximal tricuspid regurgitation pressure gradient; Ea, afterload; Ees, left ventricular end-systolic elastance/contractility.

Table 2

Change in clinical and echocardiographic parameters from admission to discharge in patients admitted to the hospital for AHF according to LVEF at discharge

AdmissionChange from admission to discharge, Δ [95% CI]
HFrEF
n = 52
HFmrEF
n = 16
HFpEF
n = 66
P-valueHFrEF
n = 52
HFmrEF
n = 16
HFpEF
n = 66
P-value
Body weight (kg)87 (20)90 (21)84 (22)0.363−4.4 (−5.7, −2.8)−3.7 (−6.2, −0.9)−2.6 (−3.8, −1.9)0.032b
NT-proBNP (pg/mL)6152 (4124, 10428)3982 (2457, 5808)2968 (1249, 6397)0.001b−3942 (−5737, −1922)−2008 (−3800, 423)−2392 (−3490, −1063)0.061b
HR (min−1)84 (19)75 (24)74 (17)0.016b−12 (−17, −7)−2 (−11, 8)−7 (−11, −3)0.059
SET (ms)244 (39)279 (36)300 (46)<0.001ab20 (11, 30)−5 (−21, 10)10 (−0, 19)0.025a
SETc (ms)269 (35)294 (27)317 (35)<0.001abc9 (1, 17)−5 (−21, 10)1 (−7, 9)0.110
LVEF (%)25 (8)46 (6)60 (11)<0.001abc11 (7, 15)3 (−1, 8)1 (−2, 3)0.004b
LVEDV (mL)161 (120, 208)100 (64, 134)79 (67, 114)<0.001 ab−9 (−20, 3)−27 (−55, 1)−5 (−12, 4)0.409
SV (mL)39 (27, 48)46 (30, 69)50 (38, 72)0.002b4 (+0, 8)−14 (−27, −1)−1 (−6, 3)0.065a
Cardiac output (L/min)3.2 (2.2, 4.2)3.7 (2.2, 4.5)3.6 (2.8, 4.8)0.222−0.2 (−0.6, 0.2)−1.1 (−2.0, −0.3)−0.5 (−0.9, −0.1)0.334
E/e´19 (13, 25)20 (16, 20)17 (12, 22)0.5904 (−7,12)13 (+0, 25)2 (−1, 5)0.577
TRmaxPG (mmHg)41 (11)41 (15)44 (14)0.502−3 (−6, + 0)−4 (−10, 2)−6 (−9, −3)0.539
Ea (mmHg/mL)2.85 (2.20, 3.76)1.94 (1.72, 3.50)2.43 (1.67, 3.07)0.038b−0.46 (−0.82, −0.05)0.63 (−0.46, 1.64)0.06 (−0.36, 0.43)0.114
Ees (mmHg/mL)0.93 (0.65, 1.20)2.28 (1.43, 2.95)3.87 (2.76, 5.22)<0.001abc0.07 (−0.06, 0.18)0.45 (−0.75, 1.60)0.18 (−0.40, 0.71)0.706
AdmissionChange from admission to discharge, Δ [95% CI]
HFrEF
n = 52
HFmrEF
n = 16
HFpEF
n = 66
P-valueHFrEF
n = 52
HFmrEF
n = 16
HFpEF
n = 66
P-value
Body weight (kg)87 (20)90 (21)84 (22)0.363−4.4 (−5.7, −2.8)−3.7 (−6.2, −0.9)−2.6 (−3.8, −1.9)0.032b
NT-proBNP (pg/mL)6152 (4124, 10428)3982 (2457, 5808)2968 (1249, 6397)0.001b−3942 (−5737, −1922)−2008 (−3800, 423)−2392 (−3490, −1063)0.061b
HR (min−1)84 (19)75 (24)74 (17)0.016b−12 (−17, −7)−2 (−11, 8)−7 (−11, −3)0.059
SET (ms)244 (39)279 (36)300 (46)<0.001ab20 (11, 30)−5 (−21, 10)10 (−0, 19)0.025a
SETc (ms)269 (35)294 (27)317 (35)<0.001abc9 (1, 17)−5 (−21, 10)1 (−7, 9)0.110
LVEF (%)25 (8)46 (6)60 (11)<0.001abc11 (7, 15)3 (−1, 8)1 (−2, 3)0.004b
LVEDV (mL)161 (120, 208)100 (64, 134)79 (67, 114)<0.001 ab−9 (−20, 3)−27 (−55, 1)−5 (−12, 4)0.409
SV (mL)39 (27, 48)46 (30, 69)50 (38, 72)0.002b4 (+0, 8)−14 (−27, −1)−1 (−6, 3)0.065a
Cardiac output (L/min)3.2 (2.2, 4.2)3.7 (2.2, 4.5)3.6 (2.8, 4.8)0.222−0.2 (−0.6, 0.2)−1.1 (−2.0, −0.3)−0.5 (−0.9, −0.1)0.334
E/e´19 (13, 25)20 (16, 20)17 (12, 22)0.5904 (−7,12)13 (+0, 25)2 (−1, 5)0.577
TRmaxPG (mmHg)41 (11)41 (15)44 (14)0.502−3 (−6, + 0)−4 (−10, 2)−6 (−9, −3)0.539
Ea (mmHg/mL)2.85 (2.20, 3.76)1.94 (1.72, 3.50)2.43 (1.67, 3.07)0.038b−0.46 (−0.82, −0.05)0.63 (−0.46, 1.64)0.06 (−0.36, 0.43)0.114
Ees (mmHg/mL)0.93 (0.65, 1.20)2.28 (1.43, 2.95)3.87 (2.76, 5.22)<0.001abc0.07 (−0.06, 0.18)0.45 (−0.75, 1.60)0.18 (−0.40, 0.71)0.706

Value are given as mean (SD) or median (Q1, Q3), as appropriate. The difference (Δ) admission to discharge was calculated subtracting the admission value from the discharge value; hence, a difference >0 indicates a prolongation of SET or SETc from admission to discharge, respectively. The respective information was available in ≥80% of participants, except for: ΔEa (n = 94), ΔLVEDV (n = 96), and E/e´ (n = 66). Pairwise comparisons, P < 0.05: a = HFrEF vs. HFmrEF, b = HFrEF vs. HFpEF, c = HFmrEF vs. HFpEF.

HFrEF, HF with reduced EF (LVEF ≤ 40%); HFmrEF, HF with mildly reduced EF (LVEF41–49%); HFpEF, HF with preserved EF (LVEF ≥ 50%); HR, heart rate; NT-proBNP, N-terminal pro B-type natriuretic peptide; SET, systolic ejection time; SETc, HR-corrected SET; LVEF, left ventricular ejection fraction; LVEDV, left ventricular end-diastolic volume; SV, stroke volume; E, early mitral inflow velocity; e´, early diastolic velocity of the mitral annulus; TRmaxPG, maximal tricuspid regurgitation pressure gradient; Ea, afterload; Ees, left ventricular end-systolic elastance/contractility.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close